AVITA Medical Dirección
Dirección controles de criterios 2/4
El CEO de AVITA Medical es Jim Corbett , nombrado en Sep 2022, tiene una permanencia de 2.17 años. compensación anual total es $2.07M, compuesta por 30.2% salario y 69.8% primas, incluidas acciones y opciones de la empresa. posee directamente un 0.033% de las acciones de la empresa, por valor de $111.65K. La antigüedad media del equipo directivo y de la junta directiva es de 1.8 años y 6.1 años, respectivamente.
Información clave
Jim Corbett
Chief Executive Officer (CEO)
US$2.1m
Compensación total
| Porcentaje del salario del CEO | 30.2% |
| Permanencia del CEO | 2.2yrs |
| Participación del CEO | 0.03% |
| Permanencia media de la dirección | 1.8yrs |
| Promedio de permanencia en la Junta Directiva | 6.1yrs |
Actualizaciones recientes de la dirección
Recent updates
AVITA Medical, Inc.'s (NASDAQ:RCEL) Share Price Boosted 26% But Its Business Prospects Need A Lift Too
Oct 04
AVITA Medical, Inc. (NASDAQ:RCEL) Consensus Forecasts Have Become A Little Darker Since Its Latest Report
Aug 11AVITA Medical, Inc.'s (NASDAQ:RCEL) Share Price Boosted 26% But Its Business Prospects Need A Lift Too
Jul 18Is AVITA Medical (NASDAQ:RCEL) A Risky Investment?
Jun 18Little Excitement Around AVITA Medical, Inc.'s (NASDAQ:RCEL) Revenues As Shares Take 39% Pounding
Apr 12AVITA Medical, Inc.'s (NASDAQ:RCEL) Price Is Right But Growth Is Lacking After Shares Rocket 39%
Feb 02The Market Doesn't Like What It Sees From AVITA Medical, Inc.'s (NASDAQ:RCEL) Revenues Yet As Shares Tumble 32%
Oct 20Avita Medical appoints James Corbett as CEO
Sep 29AVITA Medical says trial evaluating its RECELL system to treat vitiligo met main goal
Sep 12Avita's burn therapy Recell gets insurance coverage in Japan following approval
Sep 01AVITA Medical GAAP EPS of -$0.25 beats by $0.15, revenue of $8.34M beats by $1.18M
Aug 11AVITA Medical Is Interesting, But Not Just Yet
Dec 21AVITA Medical reports preliminary Q2 revenue in-line with consensus
Jan 12AVITA: COVID-19's Impact
Nov 17Análisis de compensación del CEO
| Fecha | Compensación total | Salario | Ingresos de la empresa |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | -US$57m |
| Jun 30 2024 | n/a | n/a | -US$50m |
| Mar 31 2024 | n/a | n/a | -US$45m |
| Dec 31 2023 | US$2m | US$625k | -US$35m |
| Sep 30 2023 | n/a | n/a | -US$34m |
| Jun 30 2023 | n/a | n/a | -US$31m |
| Mar 31 2023 | n/a | n/a | -US$26m |
| Dec 31 2022 | US$2m | US$157k | -US$27m |
| Sep 30 2022 | n/a | n/a | -US$30m |
| Jun 30 2022 | n/a | n/a | -US$30m |
| Mar 31 2022 | n/a | n/a | -US$29m |
| Dec 31 2021 | US$256k | n/a | -US$25m |
Compensación vs. Mercado: La compensación total ($USD2.07M) de Jim está en línea con el promedio de empresas de tamaño similar en el mercado US ($USD2.12M).
Compensación vs. Ingresos: La compensación de Jim ha aumentado mientras la empresa no es rentable.
CEO
Jim Corbett (66 yo)
2.2yrs
Permanencia
US$2,068,675
Compensación
Mr. James M. Corbett, also known as Jim, served as Chief Executive Officer of CathWorks Ltd. since October 27, 2017 until 2021. He serves as Director of CathWorks Ltd.until 2021. He served as an Independe...
Equipo directivo
| Nombre | Posición | Permanencia | Compensación | Propiedad |
|---|---|---|---|---|
| CEO, President & Executive Director | 2.2yrs | US$2.07m | 0.033% $ 111.7k | |
| Chief Financial Officer | 1.4yrs | US$2.18m | sin datos | |
| Senior Vice President of Global Operations | 1.8yrs | sin datos | sin datos | |
| Senior Vice President of Scientific & Medical Affairs | less than a year | sin datos | sin datos | |
| Investor Relations Executive | no data | sin datos | sin datos | |
| Chief Legal & Compliance Officer and Corporate Secretary | less than a year | sin datos | sin datos | |
| Senior Vice President of Global Marketing & Strategy | 6.3yrs | sin datos | sin datos | |
| Senior Vice President of Human Resources | 1.8yrs | sin datos | sin datos | |
| Senior Vice President of Product Development & Program Management | 1.8yrs | sin datos | sin datos | |
| Senior Vice President of Quality Assurance & Regulatory Affairs | 1.8yrs | sin datos | sin datos | |
| Senior Vice President of U.S. Commercial Sales | less than a year | sin datos | sin datos |
1.8yrs
Permanencia media
Equipo directivo experimentado: El equipo directivo de RCEL no se considera experimentado ( 1.8 años antigüedad media), lo que sugiere un nuevo equipo.
Miembros de la Junta
| Nombre | Posición | Permanencia | Compensación | Propiedad |
|---|---|---|---|---|
| CEO, President & Executive Director | 3.3yrs | US$2.07m | 0.033% $ 111.7k | |
| Independent Non-Executive Director | 3.3yrs | US$211.12k | 0.11% $ 371.4k | |
| Independent Non-Executive Director | 12.1yrs | US$199.87k | 0.079% $ 264.9k | |
| Founder and Member of Clinical Advisory Board | 8.8yrs | US$29.80k | sin datos | |
| Independent Non-Executive Chairman | 10.3yrs | US$234.69k | 0.16% $ 554.9k | |
| Independent Non-Executive Director | 1.6yrs | US$369.11k | 0.075% $ 252.3k | |
| Independent Non-Executive Director | 1.6yrs | US$364.94k | 0.037% $ 123.8k | |
| Independent Non-Executive Director | 8.8yrs | US$195.28k | 0.10% $ 349.9k |
6.1yrs
Permanencia media
67yo
Promedio de edad
Junta con experiencia: La junta directiva de RCEL se considera experimentada (6.1 años de antigüedad promedio).